TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26144850

Group type: EXPERIMENTAL
Intervention: ROM-6 (monthly rifampicin, ofloxacin, and minocycline for six months)
Number of subjects: 268

Group type: COMPARATOR
Intervention: PB-MDT (standard World Health Organization paucibacillary multidrug therapy)
Number of subjects: 268

Group type: COMPARATOR
Intervention: PB-MDT
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: ROM-6
Number of subjects: 268
Study: 23210452

Group type: EXPERIMENTAL
Intervention: ThermoCool Surround Flow® catheter (SFc)
Number of subjects: 106

Group type: COMPARATOR
Intervention: ThermoCool® catheter (TCc)
Number of subjects: 106
Study: 21695893

Group type: COMPARATOR
Intervention: Calcium 440 mg/d and VD 100 IU/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calcium 440 mg/d, VD 100 IU/d and soy isoflavone 100 mg/d
Number of subjects: 60
Study: 18649869

Group type: EXPERIMENTAL
Intervention: Albumin administration
Number of subjects: 127

Group type: COMPARATOR
Intervention: Saline administration (Control)
Number of subjects: 127
Study: 16433735

Group type: COMPARATOR
Intervention: sham‐AD
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: verum‐AD (disulfiram/calcium carbimide)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: long‐term AD intake
Number of subjects: 180

Group type: COMPARATOR
Intervention: AD intake between months 13 and 20
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: detrimental lapses and malignant relapses
Number of subjects: 180
Study: 15333424

Group type: EXPERIMENTAL
Intervention: sivelestat (ONO-5046) 0.2 mg/kg/h for 14 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: sivelestat (ONO-5046)
Number of subjects: 24

Group type: COMPARATOR
Intervention: conventional therapy
Number of subjects: 24
Study: 11079239

Group type: EXPERIMENTAL
Intervention: Ostracized participants
Number of subjects: 1486
Study: 9287061

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pocket reduction through osseous surgery and apically‐positioned flap (OS group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Modified Widman flap (MWF group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Modified Widman flap and topical application of saturated citric acid at pH 1 for 3 minutes (CA group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Infected sites
Number of subjects: 12
Study: 8332925

Group type: EXPERIMENTAL
Intervention: Invitation letter with an appointment
Number of subjects: 299

Group type: COMPARATOR
Intervention: Opportunistic invitation by GP
Number of subjects: 299
Study: 3446303

Group type: EXPERIMENTAL
Intervention: Time-limited therapy carried out by trainees
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 29354935

Group type: EXPERIMENTAL
Intervention: Auricular point sticking therapy combined with western medicine
Number of subjects: 123

Group type: COMPARATOR
Intervention: Western medicine only (control group)
Number of subjects: 123
Study: 26969754

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol plus parecoxib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 0
Study: 25394430

Group type: EXPERIMENTAL
Intervention: Mannitol administration to kidney donors
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (mannitol negative)
Number of subjects: 60
Study: 23697857

Group type: EXPERIMENTAL
Intervention: Intravitreal diclofenac (IVD) - 500 μg/0.1 mL
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intravitreal triamcinolone (IVT) - 2 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravitreal diclofenac (IVD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intravitreal triamcinolone (IVT)
Number of subjects: 15
Study: 20598971

Group type: EXPERIMENTAL
Intervention: Remote monitoring strategy using the CareLink network with automatic alerts for lung fluid overload, atrial fibrillation, and device integrity issues.
Number of subjects: 1720

Group type: EXPERIMENTAL
Intervention: Remote monitoring strategy using the CareLink network.
Number of subjects: 1720

Group type: COMPARATOR
Intervention: Standard in-office follow-up.
Number of subjects: 1720
Study: 18795515

Group type: EXPERIMENTAL
Intervention: NovaMin dentifrice
Number of subjects: 71

Group type: COMPARATOR
Intervention: SrCl2 dentifrice
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 71
Study: 17042147

Group type: EXPERIMENTAL
Intervention: Cetirizine hydrochloride (5 mg)‐pseudoephedrine hydrochloride (120 mg) (cetirizine‐D) twice daily
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 14572578

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Etidronate (400 mg/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Etidronate
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 32
Study: 10933081

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9412432

Group type: EXPERIMENTAL
Intervention: Exercise on a treadmill
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Resting measurements
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Heart rate measurements
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Heart rate during exercise
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Time spent on treadmill
Number of subjects: 8
Study: 8412069

Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study: 2951985

Group type: EXPERIMENTAL
Intervention: 125 micrograms/day of ICI 118,630
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 250 micrograms/day of ICI 118,630
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 500 micrograms/day of ICI 118,630
Number of subjects: 33
Study: 29091519

Group type: EXPERIMENTAL
Intervention: Customized compression orthosis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 24
Study: 28468229

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline merocel pack (Control)
Number of subjects: 0
Study: 24699556

Group type: EXPERIMENTAL
Intervention: Noncoagulating P4 protein blend
Number of subjects: 21

Group type: COMPARATOR
Intervention: Coagulating casein-dominant protein blends
Number of subjects: 21
Study: 23756263

Group type: EXPERIMENTAL
Intervention: Transfusion to raise haemoglobin to at least 10.0 g/dL
Number of subjects: 200

Group type: COMPARATOR
Intervention: No transfusion unless definite symptoms of anaemia became apparent
Number of subjects: 200
Study: 21392929

Group type: EXPERIMENTAL
Intervention: Interactive computerized education module
Number of subjects: 686
Study: 19875386

Group type: EXPERIMENTAL
Intervention: Gp IIb-IIIa inhibitors
Number of subjects: 10085
Study: 16798772

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg h(‐1) (group R, n=22)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1 mg h(‐1) with morphine 8 microg h(‐1) (group RM, n=22)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg ml(‐1) for continuous spinal anaesthesia
Number of subjects: 47
Study: 12783034

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg x d-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4000 mg x d-1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10839900

Group type: EXPERIMENTAL
Intervention: CIO (Continuous Insufflation of Oxygen) at a flow rate of 15 l/min
Number of subjects: 95

Group type: COMPARATOR
Intervention: IPPV (Intermittent Positive Pressure Ventilation)
Number of subjects: 95
Study: 9126126

Group type: COMPARATOR
Intervention: Standard surgical consultation (Control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verbalization of risks and benefits (Experimental)
Number of subjects: 20
Study: 8267430

Group type: EXPERIMENTAL
Intervention: Retrograde blood cardioplegia combined with anterograde blood cardioplegia and warm reperfusion (group 2)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia (group 1)
Number of subjects: 41
Study: 3544663

Group type: EXPERIMENTAL
Intervention: Vacuum extraction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Forceps delivery
Number of subjects: 0
Study: 29128417

Group type: EXPERIMENTAL
Intervention: SitLess
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ExMore
Number of subjects: 59
Study: 26847832

Group type: EXPERIMENTAL
Intervention: Active Hexose Correlated Compound (AHCC) 6.0 g for 2 months
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Active Hexose Correlated Compound (AHCC)
Number of subjects: 75
Study: 24596458

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Functional impairment
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Previous falls
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 328
Study: 22354671

Group type: EXPERIMENTAL
Intervention: TAP block with 15 ml 0.25% bupivacaine (group T, n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No blockade (group C, n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TAP block (group T)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No blockade (group C)
Number of subjects: 50
Study: 20113315

Group type: EXPERIMENTAL
Intervention: Cardi04-300 ml
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cardi04-150 ml
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 17030155

Group type: EXPERIMENTAL
Intervention: Intensive glucose control
Number of subjects: 1978

Group type: COMPARATOR
Intervention: Placebo controlled blood pressure lowering (ACE inhibitor-diuretic combination: perindopril-indapamide)
Number of subjects: 1978
Study: 15853986

Group type: EXPERIMENTAL
Intervention: Combination therapy with 3 or 5 MU IFN-alpha-2b thrice weekly and oral ribavirin (800-1200 mg/day) for 24 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 3 MU IFN-alpha-2b
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5 MU IFN-alpha-2b
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination therapy with IFN-alpha and ribavirin
Number of subjects: 36

Group type: COMPARATOR
Intervention: HCV infection alone (control group)
Number of subjects: 36
Study: 12030663

Group type: EXPERIMENTAL
Intervention: Combined warfarin and aspirin, low doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warfarin alone, low doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin alone, low doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10220795

Group type: EXPERIMENTAL
Intervention: Primary biliary cirrhosis (PBC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Chronic hepatitis C (CH‐C)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Large bile duct obstruction
Number of subjects: 26
Study: 10513459

Group type: EXPERIMENTAL
Intervention: Methylphenidate (three patterns of delivery)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 31
Study: 1907555

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3 ointment (1 microgram g-1) applied topically for 24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3 (10(-8) mol l-1) applied to cultured human keratinocytes for more than 9 days
Number of subjects: 0
Study: 6749271

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31814064

Group type: EXPERIMENTAL
Intervention: Ensite NavX system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional fluoroscopy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 31531421

Group type: EXPERIMENTAL
Intervention: Lignocaine liposomal infusion only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lignocaine plus epinephrine liposomal infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 0
Study: 28411507

Group type: EXPERIMENTAL
Intervention: DSM-5 criteria for hypomania/mania with mixed features
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: DSM-5 criteria for depressive episode with mixed features
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Presence of mixed features in patients with mania/hypomania
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Presence of mixed features in patients with depression
Number of subjects: 482

Group type: COMPARATOR
Intervention: DSM-IV mixed episodes diagnoses
Number of subjects: 482

Group type: COMPARATOR
Intervention: BISS assessment for mixed episodes
Number of subjects: 482
Study: 23567655

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 6729
Study: 20619353

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Salmeterol 50 μg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 18963991

Group type: EXPERIMENTAL
Intervention: ADHD children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Children with cerebellar lesions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 0
Study: 17726315

Group type: EXPERIMENTAL
Intervention: Increased consumption of vegetables (V)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Increased consumption of cereals (C)
Number of subjects: 57
Study: 14972424

Group type: EXPERIMENTAL
Intervention: Aspirin + Warfarin (1.25mg of warfarin plus 75mg of aspirin)
Number of subjects: 3300

Group type: COMPARATOR
Intervention: Aspirin (75mg)
Number of subjects: 3300
Study: 11502526

Group type: EXPERIMENTAL
Intervention: Clinafloxacin (single oral doses)
Number of subjects: 64
Study: 9210065

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (ATRA) with cytosine arabinoside (4 g/course, 1 to 9 courses every 4 weeks)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (ATRA) alone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside (4 g/course, 1 to 9 courses every 4 weeks)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (non-responder patients)
Number of subjects: 9
Study: 8425424

Group type: EXPERIMENTAL
Intervention: Resection and primary anastomosis in Group A
Number of subjects: 31

Group type: COMPARATOR
Intervention: Mesosigmoidopexy in Group A
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Hartmann's procedure in Group B
Number of subjects: 31

Group type: COMPARATOR
Intervention: Resection and primary anastomosis in Group B
Number of subjects: 31
Study: 3305464

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 110

Group type: COMPARATOR
Intervention: Cefazolin/Tobramycin
Number of subjects: 110
Study: 31559434

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet
Number of subjects: 1294
Study: 29458399

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Kinesiotape (AcuKT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 60
Study: 28242265

Group type: EXPERIMENTAL
Intervention: Free quadriceps tendon autograft
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hamstring tendon autograft
Number of subjects: 48
Study: 24547956

Group type: EXPERIMENTAL
Intervention: Stellate ganglion block (SGB)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (Corticosteroids)
Number of subjects: 96
Study: 22545585

Group type: EXPERIMENTAL
Intervention: Substance use-as-coping
Number of subjects: 0

Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 0
Study: 19660844

Group type: EXPERIMENTAL
Intervention: 20 g of casein
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 20 g of whey protein
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 15 g of whey protein combined with 5 g of essential amino acids
Number of subjects: 45
Study: 18498918

Group type: EXPERIMENTAL
Intervention: Inhibitron (test formulation)
Number of subjects: 34

Group type: COMPARATOR
Intervention: LosecA (reference formulation)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 34
Study: 15916502

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 7705

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7705
Study: 12590203

Group type: EXPERIMENTAL
Intervention: ProOsteon 200 (coralline hydroxyapatite)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Iliac crest graft (control)
Number of subjects: 29
Study: 10573278

Group type: EXPERIMENTAL
Intervention: DCLHb
Number of subjects: 112

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 112
Study: 8763463

Group type: EXPERIMENTAL
Intervention: 250 mg terbinafine daily for 12 weeks
Number of subjects: 195

Group type: COMPARATOR
Intervention: 200 mg itraconazole daily for 12 weeks
Number of subjects: 195
Study: 2038367

Group type: EXPERIMENTAL
Intervention: Prophylactic sclerotherapy
Number of subjects: 281

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 281
Study: 6337228

Group type: EXPERIMENTAL
Intervention: Gentamicin treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no gentamicin)
Number of subjects: 21
Study: 28622082

Group type: EXPERIMENTAL
Intervention: Micro-needling combined with 10% TCA cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 0
Study: 28887670

Group type: EXPERIMENTAL
Intervention: First generation steerable robotic catheter, version 1.0 (group 1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: New version steerable robotic catheter, version 1.1 (group 2)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 21
Study: 27128538

Group type: EXPERIMENTAL
Intervention: 80% oxygen during and two hours after surgery
Number of subjects: 1386

Group type: COMPARATOR
Intervention: 30% oxygen during and two hours after surgery
Number of subjects: 1386
Study: 24679046

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 IU) administered twice a day for 7.5 days
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo administered twice a day for 7.5 days
Number of subjects: 220
Study: 22223814

Group type: EXPERIMENTAL
Intervention: Drug company advertisements
Number of subjects: 544

Group type: COMPARATOR
Intervention: Other sources advertisements
Number of subjects: 544

Group type: COMPARATOR
Intervention: Logo-free advertisement
Number of subjects: 544
Study: 20649443

Group type: EXPERIMENTAL
Intervention: Balloon dilator
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Metal dilator
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Amplatz dilator
Number of subjects: 75
Study: 17656469

Group type: EXPERIMENTAL
Intervention: DPC 333 at 5.5 mg/kg daily for 2 weeks in a rat collagen antibody-induced arthritis model
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: DPC 333 (oral)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: DPC 333 (oral, single escalating doses)
Number of subjects: 1
Study: 15871635

Group type: EXPERIMENTAL
Intervention: Valganciclovir (900 mg once daily)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Oral ganciclovir (1000 mg three times daily)
Number of subjects: 364
Study: 11799030

Group type: EXPERIMENTAL
Intervention: Butterbur (carbon dioxide extract tablets, ZE 339) one tablet, four times daily for two weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Cetirizine, one tablet in the evening for two weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 125
Study: 9584823

Group type: EXPERIMENTAL
Intervention: No glove change with manual placental delivery (Group A)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: No glove change with expressed placental delivery (Group B)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Glove change with manual placental delivery (Group C)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Glove change with expressed placental delivery (Group D)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Combined no glove change (Groups A and B)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Combined glove change (Groups C and D)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Combined manual placental delivery (Groups A and C)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Combined expressed placental delivery (Groups B and D)
Number of subjects: 108
Study: 7658296

Group type: EXPERIMENTAL
Intervention: Parents who attended evening sessions of the drug prevention program
Number of subjects: 1761

Group type: EXPERIMENTAL
Intervention: Students whose parents completed the survey
Number of subjects: 1761

Group type: COMPARATOR
Intervention: Students whose parents did not complete a survey
Number of subjects: 1761
Study: 2096106

Group type: EXPERIMENTAL
Intervention: 4 mg dimethindene maleate (Fenistil, Tropfen)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 8
Study: 1015353

Group type: EXPERIMENTAL
Intervention: Postmyocardial Infarction Clinic treatment
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (not treated at the clinic)
Number of subjects: 96
Study: 30941580

Group type: EXPERIMENTAL
Intervention: HNCP (Head and Neck Cancer Survivor Self-Management Care Plan)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Information about survivorship
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study: 28926885

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) therapy with energy of 14-16 J/cm²
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control eye receiving placebo therapy with 0 J/cm²
Number of subjects: 44
Study: 25639487

Group type: EXPERIMENTAL
Intervention: Pilocarpine mouthwash
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water rinse (control)
Number of subjects: 40